Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.
about
Gonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent mannerHeroes in endocrinology: Nobel Prizes.Tachykinin neurokinin 3 receptor antagonists: a patent review (2005 - 2010).AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia.Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix.Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125A career pathway in protein folding: from model peptides to postreductionist protein sciencePotentiating effects of GHRH analogs on the response to chemotherapy.Cancer treatment using peptides: current therapies and future prospectsIndirect androgen doping by oestrogen blockade in sports.Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone.Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31.Augmentation of gonadotropin-releasing hormone receptor expression in the post-lactational mammary tissues of rats.Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma.Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonistsRole of Ovarian Function Suppression in Premenopausal Women with Early Breast Cancer.Receptor-mediated tumor targeting based on peptide hormones.Nerve growth factor signaling in prostate health and disease.Emerging treatment options for benign prostatic obstruction.Thymic involution: where endocrinology meets immunology.Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH).Gonadotropin-releasing hormone targeting for gonadotroph ablation: an approach to non-surgical sterilization.Agonists of luteinizing hormone-releasing hormone in prostate cancer.Can side effects of steroid treatments be minimized by the temporal aspects of delivery method?GnRH and GnRH receptors in the pathophysiology of the human female reproductive system.Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment.Overview of elagolix for the treatment of endometriosis.Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone AnalogsStability, permeability and growth-inhibitory properties of gonadotropin-releasing hormone liposaccharides.Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC).Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.An efficient chemical approach to bispecific antibodies and antibodies of high valencyAn update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer.Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patientsRecent Development of Non-Peptide GnRH Antagonists.Therapeutic outcomes of the LHRH antagonists.
P2860
Q28537723-BC7DC88F-62BF-421B-93A9-13A9FD95FAB1Q34118158-F48E95EB-0BBC-4CA0-A6E8-A406392D0B4DQ34171734-068FD7F7-0E7F-4623-8F03-B82FF4D2D42FQ34274245-E3E2DD8E-177D-48B9-97E3-85B935557732Q34529072-390435C1-32BC-48CB-A27D-2CA67F075F4DQ34888651-FB7DC17E-FAC2-4452-9E76-BDC77E1E1611Q34894406-A91CC78E-113F-46DC-9563-347F4B3D4BA8Q35075859-85568D67-18BD-4F9C-B963-03406A7A5B9BQ35565027-16D2334A-2FF8-4076-B3F5-D2E413FD2B7BQ36515785-1F1F9058-82B2-4973-B124-5A7DA9FE9F5FQ36736110-0B77B002-4BA1-42B1-BE7C-60E5D748A142Q37029375-863B7BB3-039A-4223-ACEA-200E0746AC40Q37157310-91FB08E4-8F3F-40FE-8626-51BCB584495DQ37171278-E9B865E3-F4D6-425E-8DAA-A66B9E808673Q37369730-2A78ADDC-993F-4B57-B894-F50ECE60A637Q37381602-ACFB17E5-5C6B-4B01-B6EF-D7FAF6DEFD65Q37495105-35642686-99F0-418F-91BE-6D9A1807FE8BQ37547937-4A0E9DE3-32C9-4DC8-B165-C9813A635F3EQ37641368-6BCA5120-0001-4C32-9436-D9E8807C6D79Q37694590-81B2036E-DEA4-4FEC-9774-293C8E6C26C8Q37863036-7EA57C46-3BD6-4B1B-ABED-CEB409056378Q37939600-AA15A163-B270-4468-8EDC-A379BE5E5E8CQ38007373-D97E93EC-0B7E-4640-B4F8-C4DECEEE91D5Q38029046-A6FD29BA-2082-4F5E-B21D-2231B7C0B0C0Q38132229-BF18AD8C-B753-46DC-87B5-904BFCB96745Q38254723-15F5BBA9-3A87-4497-BBCD-68A5ED2822CDQ38682630-F00F88B2-C49A-4535-B987-4BABAA7E709FQ38767147-B03E6833-FC02-41E4-A942-2C30F06BD29AQ38791644-7583A299-66E8-4F0C-99C5-FD5817EDA6C4Q38877441-B11E5A31-4B39-4FAC-BEB9-71E183D9FA4CQ38939445-E3ED797B-B617-4314-8A7F-AD2DD791653BQ38949880-0AEF977E-C877-423C-B35F-5D00EC8DF91EQ39201247-CEA3C46B-6BD2-4124-8937-C6A1A9FE6268Q39267156-3F197AA5-805E-471B-9663-47D7C60D0872Q39842559-32F971F5-EE87-4A23-BF4E-88FBC4630261Q40018470-C3986574-1C78-4E53-BDC9-70DDA0135FC7Q42117021-94EADA82-019E-4A48-8BF1-EBE573B568AFQ42654761-E422360C-7D04-4D92-9989-0F98291B9B28Q47323557-3C6668D9-F30A-40E2-A2D4-73754540686CQ47859553-4DE354BE-174D-4425-B5DA-B0060D426835
P2860
Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Drug Insight: clinical use of ...... ing-hormone-releasing hormone.
@ast
Drug Insight: clinical use of ...... ing-hormone-releasing hormone.
@en
Drug Insight: clinical use of ...... ing-hormone-releasing hormone.
@nl
type
label
Drug Insight: clinical use of ...... ing-hormone-releasing hormone.
@ast
Drug Insight: clinical use of ...... ing-hormone-releasing hormone.
@en
Drug Insight: clinical use of ...... ing-hormone-releasing hormone.
@nl
prefLabel
Drug Insight: clinical use of ...... ing-hormone-releasing hormone.
@ast
Drug Insight: clinical use of ...... ing-hormone-releasing hormone.
@en
Drug Insight: clinical use of ...... ing-hormone-releasing hormone.
@nl
P356
P1476
Drug Insight: clinical use of ...... zing-hormone-releasing hormone
@en
P2093
Jörg B Engel
P2860
P304
P356
10.1038/NCPENDMET0399
P577
2007-02-01T00:00:00Z